Aesica Prepares for Further European Expansion with New Appointment
Aesica Pharmaceuticals has announced the appointment of Marion Köppe as Regional Sales Manager – Eastern Europe, to promote the full range of Aesica contract development and manufacturing services to the regional pharmaceutical industry.
Originally from Hohenmölsen, Germany, Marion, 32, started her career in pharmaceuticals in 2004 after completing a degree at the University of Applied Science, Anhalt. She began working for the pharmaceutical company, Schwarz, at its Zwickau site, which was taken over by UCB and subsequently by Aesica in early 2011. Marion will relocate to the Aesica Monheim office in order to fulfill her new role.
Speaking of her appointment Marion said: “As a previous employee of UCB, I’m delighted to accept this position and to contribute to the strengthening of Aesica’s presence and offering within Europe. I am very much looking forward to working closely with the team at Aesica across the three Business Units (API, R5 Formulation Development and Formulated Products) within Europe and beyond.”
Dr. Alan Raymond, Sales & Marketing Director, said: “When we acquired three sites from UCB in early 2011 all staff transferred to Aesica, which meant that we gained many talented and specialist individuals. Marion is one of these very talented individuals and her promotion is of particular significance, as she is the first UCB employee to be promoted internally since the acquisition and we wish her every success in her new role with Aesica.”
Aesica is a leading full-service provider of contract research, development and manufacturing services for Formulated Products and Active Pharmaceutical Ingredients. The company develops long-term strategic partnerships with its clients, responds quickly and effectively to market demand and develops tailored solutions for specific requirements.